[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 20, Issue 3 (Bimonthly 2016) ::
Feyz 2016, 20(3): 267-273 Back to browse issues page
Carbapenemase-producing Klebsiella pneumoniae strains among clinical specimens in Kashan (2014-2015)
Mehdi Agha-Seyed Hosseini, Farzaneh Firoozeh *, Ahmad Piroozmand, Hamid Reza Gilasi
Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, I. R. Iran. , ffiroozeh@ut.ac.ir
Abstract:   (3632 Views)

Background: Resistance among the Enterobacteriaceae family especially in Klebsiella genus as one important leading cause of nosocomial infection, is one of the most important health challenges all over the world. Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria are among the most prevalent β-lactamases in Klebsiella strains. Our aim was to study KPC-producing Klebsiella strains in clinical samples in Kashan.

Materials and Methods: In this cross-sectional study Klebsiella isolates (n=181) were recovered from clinical samples during September to July 2015. After identification of Klebsiella isolates by biochemical tests, the susceptibility pattern of recovered Klebsiella from clinical isolates to 17 antibiotics were studied by disk diffusion method. Using PCR assay blaKPC gene in Klebsiella isolates were studied. Statistical analyses of data were performed by Chi square test and (P<0.05) was considered statistically significant.

Results: Forty eight out of 181 Klebsiella samples were multidrug resistant and the most resistant was seen to Ampicillin and Cephalotin. Among the Klebsiella isolates, 21(11.6%) carried blaKPC gene which most of them were recovered in ICU ward from urinary and respiratory specimens.  

Conclusions: Our study showed that in Klebsiella strains isolated from patients, especially hospitalized patients in Kashan, resistance to carbapenems is seen with presence of blaKPC gene. Due to the ability of gene to spread by mobile genetic elements the finding is alarming in treatment of Klebsiella infections.

Keywords: Klebsiella, Multi-drug resistance, blaKPC, Carbapenemases
Full-Text [PDF 283 kb]   (4468 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2016/08/10 | Accepted: 2016/08/10 | Published: 2016/08/10
1. Guzmán-Blanco M, Labarca JA, Villegas MV, Gotuzzo E. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis 2014; 18(4): 421-33.
2. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8(3): 159-66.
3. Falade AG, Ayede AI. Epidemiology, etiology and management of childhood acute community-acquired pneumonia in developing countries--a review. Afr J Med Med Sci 2011; 40(4): 293-308.
4. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012; 27(2): 128-42.
5. Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, et al. Epidemiology and antimicrobial susceptibility profiles of gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 2012; 40 Suppl: S37-43.
6. Chen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Infect Dis Clin North Am 2009; 23(4): 817-45.
7. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumonia carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65(6): 1119-25.
8. Gootz TD. The global problem of antibiotic resistance. Crit Rev Immunol 2010; 30(1): 79-93.
9. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis 2011; 11(5): 381-93.
10. Walther-Rasmussen J, Høiby N. Class A carbapenemases. J Antimicrob Chemother 2007; 60(3): 470–82.
11. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24 (Suppl 1): S19–45.
12. da Silva RM, Traebert J, Galato D. Klebsiella pneumoniae carbapenemase (KPC) producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. Expert Opin Biol Ther 2012; 12(6): 663-71.
13. Green VL, Verma A, Owens RJ, Phillips SE, Carr SB. Structure of New Delhi Metallo-β-Lactamase 1 (NDM-1). Acta Crystallogr Sect F Struct Biol Cryst Commun 2011; 67(Pt 10): 1160-4.
14. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. Wayne PA, USA 2012. 21th informational supplement, M100-S22.
15. Cuzon G, Naas T, Nordmann P. KPC carbapenemases: what is at stake in clinical microbiology?. Pathol Biol (Paris) 2010; 58(1): 39-45.
16. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumonia isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009; 30(7): 666-71.
17. Hashemizadeh F, Zamanzad B, Jahandideh S, Ansari N, Gholipour A, Hashemizadeh F, et al. Identification of KPC-producing Klebsiella pneumoniae in clinical samples in Iran. Yafteh 2013; 15(1): 105-14.
18. Shokri D, Mobasheri Zadeh S, Norouzi Baruq M, Yaran M. Isolation and identification of carbapenemase KPC producing strains of Enterobacteriaceae and determination of their antibiotic susceptibility patterns. J Isfahan Med Sci 2013; 31(248): 1247-56.
19. Mohammadimehr M, Feizabadi M, Bahadori A. Antibiotic resistance pattern of gram negative bacilli caused nosocomial infections in ICUs in khanevadeh and golestan hospital in Tehran-2007. Ann Mil Health Sci Res 2011; 8(4): 283-90.
20. Langarizadeh N, Ahangarzadeh Rezaee M, Aghazadeh M, Hasani A. Prevalence of multi-drug resistant (MDR) Klebsiella pneumonia among children and adults with urinary tract infection referred to Tabriz teaching hospitals. Quarterly J Biol Sci 2011; 1(4): 9-17.
21. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005; 56(1): 128-32.
22. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 2008; 52(2): 570-3.
23. Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D. High prevalence of KPC-2-Type carbapenemase coupled with CTX-M-type extended-spectrum β-Lactamases in carbapenem-resistant Klebsiella pneumoniain a teaching hospital in China. Antimicrob Agents Chemother 2011; 55(5): 2493-4.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Agha-Seyed Hosseini M, Firoozeh F, Piroozmand A, Gilasi H R. Carbapenemase-producing Klebsiella pneumoniae strains among clinical specimens in Kashan (2014-2015). Feyz. 2016; 20 (3) :267-273
URL: http://feyz.kaums.ac.ir/article-1-3086-en.html

Volume 20, Issue 3 (Bimonthly 2016) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4148